CLINICAL_TRIALS trial_result · 2024-10-08

Clinical Trial Update: A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD [Phase 1]

A Phase 1 trial of LY3002813 in participants with memory impairment due to Alzheimer's disease has completed, with results posted on 2024-10-08.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-10-08